205470.KQ
Humasis Co. Ltd. [205470.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
205470.KQ Stock Summary
Top 10 Correlated ETFs
205470.KQ
Top 10 Correlated Stocks
205470.KQ
In the News
205470.KQ Financial details
Company Rating
-
Market Cap
242.34B
Income
-55.42B
Revenue
13.83B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
175
Optionable
No
Shortable
Yes
Earnings
-
P/E
-3.1
Forward P/E
-
PEG
0.24
P/S
14.64
P/B
0.75
P/C
-
P/FCF
-1.97
Quick Ratio
3.95
Current Ratio
4.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-435.51
EPS next Y
-
EPS next Q
-
EPS this Y
-131.22%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
108.92%
Revenue last 5Y
8.61%
Revenue Q/Q
-20.92%
EPS Q/Q
-2354.49%
-
-
-
-
SMA20
-5.29%
SMA50
-17.47%
SMA100
-25.35%
Inst Own
-
Inst Trans
-
ROA
-20%
ROE
-23%
ROC
-0.24%
Gross Margin
-273%
Oper. Margin
-454%
Profit Margin
-463%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1622.0-4385.0
52W High
-69.19%
52W Low
-16.71%
RSI
39.04
Rel Volume
0.15
Avg Volume
3.27M
Volume
479.43K
Perf Week
-2.88%
Perf Month
-16.19%
Perf Quarter
-26.13%
Perf Half Y
-10.83%
-
-
-
-
Beta
-0.879
-
-
Volatility
18.88%, 75.14%
Prev Close
-2.31%
Price
1351
Change
-1.39%
Company Profile
- Volume Average 3.27M
- Market Capitalization 242.34B
- Employee 175
- CEO Sung-gon Kim
- Headquarters Anyang,KR
- IPO Date 2017-09-27
-
Website
http://www.humasis.com 
Humasis Co. Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. It offers pregnancy and ovulation self-test products; Hubi-Quan Pro, a self-contained and cartridge reader to provide rapid quantitative results for membrane-based lateral flow immunochromatographic assays; and various rapid test kits. The company was founded in 2000 and is based in Anyang, South Korea.
